NT-proBNP (N-terminal pro-B-type natriuretic peptide) is a piece of a protein measured in the blood that increases when the heart is under strain. Pulmonary hypertension is high blood pressure in the arteries that carry blood from the heart to the lungs. In this condition, NT-proBNP can help show how the heart is coping and help clinicians estimate risk, but it cannot diagnose pulmonary hypertension on its own.
What does NT-proBNP measure?
NT-proBNP is a substance released into the blood when the heart is working under increased pressure or stretching. Heart muscle cells produce a larger protein called proBNP, which is then split into two parts: biologically active B-type natriuretic peptide (BNP) and NT-proBNP. A blood test measures the amount of NT-proBNP circulating in the bloodstream.
Doctors use this test as a marker of stress on the heart. Higher levels can indicate that the heart is working harder than usual, although the result does not identify the underlying cause by itself. According to MedlinePlus, NT-proBNP testing is commonly used when evaluating possible heart failure and can also help assess heart strain associated with pulmonary hypertension.
NT-proBNP and BNP are closely related, but they are different substances. Their blood tests use different reference ranges, so their numerical results should not be compared directly. Both can provide useful information about the heart's condition when interpreted alongside symptoms, examination findings, and other investigations.
How is NT-proBNP connected to pulmonary hypertension?
Pulmonary hypertension (PH) occurs when pressure in the blood vessels of the lungs is abnormally high. These vessels carry blood from the right side of the heart to the lungs, where it receives oxygen. When pressure in these vessels rises, the right ventricle, the heart's lower right chamber, may need to work harder to move blood through the lungs.
Increased strain on the heart can lead to higher NT-proBNP levels. In people with pulmonary arterial hypertension (PAH), a type of pulmonary hypertension, the result can help clinicians assess how the heart is responding to the condition and estimate the risk of future complications. However, elevated NT-proBNP is not specific to pulmonary hypertension. It may also occur with other heart conditions, kidney problems, and certain lung disorders.
The 2022 European Society of Cardiology and European Respiratory Society guidelines include BNP or NT-proBNP measurements in the assessment of pulmonary arterial hypertension. These biomarkers are considered together with functional ability, exercise capacity, heart imaging, and measurements of heart and lung circulation rather than used as a stand-alone measure.
What can a high NT-proBNP result mean?
An elevated NT-proBNP result suggests that the heart may be under increased strain, but its meaning depends on the person's overall health and the reason the test was ordered. In someone being evaluated for pulmonary hypertension, a high result may raise concern about heart involvement, especially when other findings also point toward pressure or strain affecting the right side of the heart.
Other conditions can also increase NT-proBNP, including left-sided heart failure, other forms of heart disease, kidney dysfunction, and pulmonary embolism, which is a blood clot in the lungs. The Cleveland Clinic explains that NT-proBNP levels may be affected by these conditions as well as by factors such as age and body weight. This is why a result needs to be interpreted using the person's medical history and other test findings.
A high value does not automatically mean that pulmonary hypertension is present or that the condition has reached a particular stage. Similarly, a result within the laboratory's reference range cannot, on its own, exclude pulmonary hypertension when other findings raise concern. The meaning of the result depends on the full clinical picture.
What NT-proBNP level is considered normal?
There is no single NT-proBNP threshold that can diagnose pulmonary hypertension or reliably describe its severity in every person. Reference ranges used in general heart-failure assessment differ from the thresholds that specialist teams may use to estimate risk in people with established pulmonary arterial hypertension.
Interpretation also depends on age, kidney function, the laboratory method, and the clinical setting. NT-proBNP levels tend to differ across age groups, and adult reference ranges should not automatically be applied to children. The laboratory's stated reference range is useful, but a value outside that range does not explain the cause of the change.
For people already receiving care for pulmonary arterial hypertension, clinicians may use NT-proBNP thresholds within a validated risk-assessment approach. These thresholds are intended to support clinical decisions in a specific setting; they are not universal cutoffs for diagnosing the condition in the general population.
How do doctors use NT-proBNP to monitor pulmonary hypertension?
For someone with diagnosed pulmonary arterial hypertension, NT-proBNP can help show whether the heart's strain may be changing over time. Clinicians may compare results from different appointments to look for trends. A rising result can prompt further assessment, while a falling result may be consistent with reduced heart strain. Neither change should be interpreted in isolation.
Monitoring usually combines NT-proBNP measurements with information about breathlessness, fatigue, physical activity, exercise-test performance, echocardiography, and, when appropriate, detailed measurements of pressure and blood flow. The European Society of Cardiology's pulmonary hypertension guidelines support a combined approach to assessing disease status and future risk. Kidney function, other medical conditions, and changes in overall health can also influence test results.
A clinician may repeat the test when symptoms change, during routine follow-up, or after treatment adjustments. The timing depends on the person's condition and care plan. A single result is a snapshot; the pattern over time, together with other clinical findings, often provides more useful information.
Can NT-proBNP diagnose pulmonary hypertension?
No. NT-proBNP is a blood marker of heart strain, not a direct measurement of pressure in the pulmonary arteries. It can support an evaluation when pulmonary hypertension is suspected, but it cannot establish the diagnosis or determine its cause by itself.
According to the National Heart, Lung, and Blood Institute (NHLBI), evaluating pulmonary hypertension may involve a medical history, physical examination, blood tests, electrocardiography (ECG), echocardiography, and other tests selected according to the suspected cause. An echocardiogram uses sound waves to assess heart structure and function and to help estimate the likelihood of pulmonary hypertension.
If pulmonary hypertension is suspected from the initial assessment, right heart catheterization may be needed to confirm the diagnosis. During this procedure, a specialist guides a thin tube through a blood vessel into the right side of the heart and the pulmonary artery to measure pressures directly. Further investigations may be used to identify whether the condition is related to heart disease, lung disease, or another cause.
When should you discuss an NT-proBNP result with a doctor?
Discuss the result with the healthcare professional who ordered the test, especially if it is outside the laboratory's reference range or has changed substantially since an earlier measurement. It is helpful to review the number, its units, previous results, current symptoms, existing heart or kidney conditions, and any other recent investigations together.
Breathlessness during everyday activities, unusual fatigue, dizziness, chest discomfort, or swelling in the legs may occur in people with pulmonary hypertension, but these symptoms can also have other causes. Persistent or worsening symptoms should be medically evaluated even when NT-proBNP is not elevated. Sudden severe breathlessness, fainting, or chest pain that is severe or persistent warrants urgent medical attention.
The main value of NT-proBNP is that it adds information about the heart's response to strain. When combined with clinical assessment and appropriate testing, it can help healthcare professionals evaluate suspected pulmonary hypertension and monitor people who are already receiving care for the condition.